- Supply TypeManufacturer, Exporter, Supplier
- Preferred Buyer Location All over the world
Lumaglobe Tablets contain a fixed combination of 2 antimalarial active ingredients, artemether, an artemisinin derivative, and lumefantrine. Lumaglobe Tablets are indicated for treatment of acute, uncomplicated malaria infections due to Plasmodium falciparum in patients of 5 kg bodyweight and above. A 3-day treatment schedule with a total of 6 doses is recommended for adult patients with a bodyweight of 35 kg and above